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INTRODUCIION
THE FALLOPIAN TUBES were first visualised radiologically as far back as
1909 by Nemenow and by Rindfleisch (quoted from Gillespie, 1965). The use of
an iodized oil as a contrast medium was reported by Sicard and Forrestier in
1922. In 1926 Beclere in France, and Rubin and Bendick in the United States
were the first investigators to report the use of lipiodol for the determination of
tubal patency.
Hysterosalpingography has a dual purpose, to demonstrate any abnormalities
congenital or otherwise of the uterus and tubes and also to act as a therapeutic
measure. White and Green-Armytage stated that it was of unquestionable thera-
peutic value probably by virtue of the medium used with its small nascent iodine
content.
The purpose of this study was to assess the number of conceptions following
this procedure in cases of infertility, and also to compare the effects of Salpix
(Ortho) and Liipiodol (May and Baker).
SELECION OF CASES
Five hundred patients who had attended the infertility clinics were sent a reply
paid letter requesting the patient to fill out a questionnaire (Table I). All these
patients were involuntarily infertile for at least two years. Hystersalpingography is
carried out as part of the routine investigation of infertility.
TABLE I
Name: Age:
Years married:
No. of children before X-ray None/ (number)
Past History: Abdominal operations (e.g. appendicitis)
How soon did you become pregnant after the X-ray (hysterosalpingogram)?
Circle where appropriate: Not at all
1 month
3 months
6 months
1 year
2 years
Did you have any symptoms following the X-ray? Yes/No
If so was the X-ray painful? If so, where?
Shoulder
Chest
Abdomen
Back
Did you feel faint/weak/nausea?
Did it upset your menstrual cycle: Yes/No.
61MATERIALS
There are basically two types of contrast media in use for hysterosalpingography,
one a water soluble material, for example Salpix, and the other an oily medium,
for example Lipiodol.
Salpix was introduced in 1953 and consists of 53 per cent sodium acetrizoate
with poly-vinyl pyrrolidine (P.V.P.) as a carrier medium. It has advantages over
oily media as do other water soluble materials in that it does not cause emboli,
has a quicker rate of absorption from the peritoneal cavity and also gives a better
demonstration of uterine mucosal relief (Gillespie, 1965). Salpix however can
cause abdominal pain (Griffiths, 1969) lasting up to two days (Sheach, 1959), and
if peritoneal irritation does occur more severe reactions may be encountered than
with oily media.
Lipiodol is a poppy-seed oil containing organically bound iodine. The main
criticisms of its use are: the occasional intravasation into uterine veins and the
occurrence of oil emboli; retention of medium in the fallopian tubes stimulating a
foreign body reaction with granulomatous inflammation and iodine idiosyncrasy.
The advantages of Lipiodol are: the contrast in the X-rays is superior; the delayed
absorption gives a better 24 hour picture and may be a factor in maintaining
tubal patency for a longer period of time. Gillespie (l965) reports a much better
conception rate with Lipiodol than with water soluble media.
TECHNIQUE
The test was carried out between the 7th and 12th day of the patient's menstrual
cycle. This is considered important for three reasons (Cron, 1965). Firstly, restora-
tion or improvement of tubal patency several days before ovulation enhances
the possibility of pregnancy. Secondly, it is unlikely that an early pregnancy will
be disturbed and thirdly, the danger of embolism appears to be less at this time.
The procedure was generally performed on an out-patient basis without sedation.
The patient reported to the radiology department having fasted for six hours.
The patient was placed on the radiology couch in the dorsal position. The vulva
and vagina were washed with "Savlon" and a bivalve vaginal speculum inserted.
The cervix was grasped with a tenaculum forceps and a Leech-Wilkinson cannula
inserted into the cervix. By exerting pressure on the cannula and counter-traction
on the forceps, a watertight junction was obtained with the cervix. Five to eight
ml. of normal Salpix or Lipiodol was slowly injected without undue pressure while
the uterus and fallopian tubes were being screened. In an occasional patient as
much as 15 ml. was used. Care was taken that the contrast media filled the cannula
before it was injected into the uterine cavity since air bubbles may produce an
artefact. One or sometimes two X-rays were taken at some time during the
procedure to demonstrate any abnormality or free spill from the fallopian tubes.
If there was any doubt about spill a 24 hour film was taken.
Over the past 5 to 10 years hysterosalpingography has been improved by the
use of image intensification and it is possible to record the process of the filling
of the uterus and tubes with intraperitoneal spill if it occurs, or to take spot
X-rays.
62RESuLTS
Two hundred and forty-eight patients (49 per cent) out of the five hundred
replied.
Eighty-three per cent of the patients were between 20 and 30 years of age and
the periods of infertility varied from two to five years. Of the total 248 patients,
82 (33 per cent) were pregnant 2 years after the procedure. Table IL illustrates the
time interval between hysterosalpingography and conception. Fifty-four per cent
conceived within three months and 29 per cent between three and six months.
It can be concluded that 83 per cent of the patients who became pregnant did so
within six months of hysterosalpingography.
Of the primary infertility group of 202 women 27 per cent became pregnant,
whereas in the secondary infertility group of 46 subjects 59 per cent became
pregnant. A higher pregnancy rate following hystersalpingography in secondary
compared with primary infertility is well known (Cron, 1965; Geary et al., 1969).
TABLE II
Conception in 82 patients following hysterosalpingogram
Number Percentage
0-3 Months 44 54 8
3-6 Months 24 29 J
6-12 Months 10 12
1-2 Years 4 5
The selection of patients may have affected the results of this study. It could
be argued that a higher percentage of non-pregnant patients would reply to the
questionnaire in the hope that something could be done for them. However, if this
was in fact the case, one would not have expected such a high percentage of
success in the secondary infertility group.
The contrast media used made no difference to the number becoming pregnant
in this study. This is in contrast to the findings of Gillespie (1965); using Lipiodol
in 1958, 41 per centof patientsconceived within one yearof hysterosalpingography,
changing to a water soluble contrast medium only 27 per cent conceived; then
changing back to Lipiodol again the conception rate returned to 44 per cent.
Salpix caused a higher incidence of nausea and abdominal pain than did the
Lipiodol (Table III). A series of 52 patients given Salpix, Griffiths (1969) reported
that 33 experienced abdominal pain, 2 nausea, 6 faintness and 3 collapsed. In
the same paper, patients who were given Urografin (another water soluble medium)
had an even higher incidence of side effects.
TABLE III
Comparison of Saipix and Lipiodol
Total Pregnant Nausea Pain
Salpix 60 20 (33%) 12 (20%) 36 (60%)
Lipiodol 188 62 (33%) 4 ( 2%) 42 (24%)
248 82 (33%) 16 ( 6%) 78 (31%)
63There were 37 (15 per cent) abnormal hysterosalpingograms; the results are
shown in Table IV. The principal abnormality was unilateral blockage. No tubes
were demonstrated in three patients. Paracervical isoxsuprine or inhalation of
amyl nitrate was not used in these patients in an attempt to counteract tubal spasm
should it have existed. It is interesting to note that only four patients with one
patent tube became pregnant in the whole series.
TABIL IV
Abnormal hysterosalpingography findings
One tube only outlined 19 (8%)
Bilateral hydrosalpingx 7 (Y%)
Filling defect in uterine cavity (fibroids) 5 (2%)
No tubes outlined 3 (1 %)
Bicornate uterus 3 (1 %)
Unicornate uterus 1 (0.25)%
38 (15%)
DISCUSSION
The advantages of hysterosalpingography in established tubal patency are well
recognised and its value in diagnosing congenital abnormalities of the uterus
cannot be surpassed. In this small series some 15 per cent of abnormalities have
been found.
Before an e-valuation of the effectiveness of any therapy can be made a reason-
ably accurate knowledge of the behaviour of untreated infertile couples should be
acquired. It has been found by many workers (Weir and Weir, 1961; Saulton,
1960), that ten per cent of all couples arrive at the end of their reproductive life
without any children, whilst Buxton and Southam (1955) reported an impressively
large series of patients attending an infertility clinic who had a 15 to 19 per cent
conception rate. The available medical literature on hysterosalpingography
indicates variation in the conception rate following this procedure (18-75 per cent).
Many factors account for this discrepancy: (i) the duration of infertility prior to
hysterosalpingography; (ii) the length of time after the procedure to the time of
conception; (iii) whether other forms of treatment were used simultaneously or
preceded hysterosalpingography.
It is suggested that the therapeutic effect of hysterosalpingography acts by
causing mechanical clearing of the tubes by dislodging mucous or breaking down
fine adhesions. Robins and Shapira (1931) demonstrated the release of tubal
adhesions by the injection of Lipiodol in a post mortem specimen. Other possibili-
ties are: (i) bacteriostatic action upon the mucous memibranes of the uterus and
tubes; (ii} stimulation of ciliary activity of the tubal epithelium; (iii) the iodine
may stimulate the activity and longevity of the spermatozoa; (iv) a more favourable
environment may be established for the ascent and penetration of the spermatozoa;
and (v) iodine may have fibrinolytic value in reducing the oedema of the tubal
wall.
64The results in this series using either I>piodol or Salpix are significant and it is
our contention that hysterosalpingography plays an important role in -the treatment
of infertility. This opinion is shared by many workers (Weir et al., 1961; Green-
Armytage, 1943; Cron, 1965). Many factors must be evaluated in treating infertility
and more than one factor may be involved. Hysterosalpingography is not the
panacea for all infertile females, it is however useful in excluding tubal and uterine
factors and, as pregnancy occurs within three months in 50 per cent, the possibility
of a therapeutic effect must exist.
SUMMARY
Two hundred and forty-eight hysterosalpingograms have been reviewed. The
primary indication for the testwas infertility. Therewasan overall pregnancy rate of
33 per cent. The pregnancy rate of the primary infertility groupwas 27 percent and
59 per cent in the second secondary infertility group. Of the patients who became
pregnant 83 per cent did so within six months. There was no difference in the
percentage becoming pregnant following the use of Salpix or Lipiodol. Uterine
or tubal abnormalities were found in 15 per cent of the cases. It is suggested that
hysterosalpingography has a therapeutic effect in overcoming the tubal factor in
infertility.
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